President & COO Joseph Hazelton indicated that since stepping into the President's role in June 2025, the company has accelerated its transition "from a development stage platform company into a ...
Good evening, and welcome to Dyadic International Full Year 2025 Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, March 25, 2026. I would now like ...
Shifted corporate strategy from a development-stage platform to a commercial, product-driven model focused on life sciences, food, and bioindustrial markets. Completed a corporate rebranding to Dyadic ...
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production platform, with Dyadic eligible to receive a share of profits from product sales ...
ADAM JAKUBIK is an economist in the IMF’s Strategy, Policy, and Review Department. ELIZABETH VAN HEUVELEN is a senior economist in the IMF’s Strategy, Policy, and Review Department. Opinions expressed ...
Chronic heart failure (CHF) in China is characterized by high readmission rates, often linked to suboptimal discharge preparedness. Current discharge planning research predominantly relies on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results